Comparative expression of major histocompatibility complex (MHC) antigens on CD5+ and CD5- B cells in patients with chronic lymphocytic leukaemia (CLL)

European Journal of Cancer

Volumn 34, Issue 10, 1998, Pages 1618-1622

  Nouri, A M E ^a   Smith, S ^b   Newland, A C ^b   Macey, M G ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CLL; Immune system; Leukaemia; MHC antigens

Indexed keywords

CD5 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; TRANSFERRIN RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CELL SUBPOPULATION; CHRONIC DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLONAL ANERGY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOFLUORESCENCE; LEUKEMIA CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; TARGET CELL;

ANTIGENS, CD5; ANTIGENS, NEOPLASM; B-LYMPHOCYTES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MAJOR HISTOCOMPATIBILITY COMPLEX;

EID: 0032168148     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00158-0     Document Type: Article

References (30)

1. 1. Zinkernagal RM, Doherty PC. MHC cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction specificity. Adv Immunol 1979, 27, 51.
2. 2. McMichael AJ, Ting A, Zweerink HJ, Askonas BA. HLA-restriction of cell mediated lysis of influenza virus infected human cells. Nature 1977, 270, 524.
3. 3. Hui K, Grosveld F, Festensein H. Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated transformation. Nature 1984, 132, 311.
4. 4. Fleming KA, McMichael A, Morton JA, Woods J, McGee JOD. Distribution of HLA class I antigens in normal human tissue and in mammary cancer. J Clin Pathol 1981, 34, 779.
5. 5. Masucci MG, Torsteindottir S, Colombani J, et al. Down-regulation of class I HLA antigens and Epstein-Barr virus encoded latent membrane protein in Burkitt's lymphoma lines. Proc Natl Acad Sci 1987, 84, 4567.
6. 6. Rees RC, Buckle AM, Gelsthorpe, et al. Loss of polymorphic A and B locus antigens in colon carcinoma. Br J Cancer 1988, 57, 374.
7. 7. Smith MEF, March SGE, Bodmer JG, Gelsthorp K, Bodmer WF. Loss of HLA A,B,C allelle products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc Natl Acad Sci 1989, 86, 5557.
8. 8. Nouri AME, Smith MEF, Crosby D, Oliver RTD. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma. Br J Cancer 1989, 62, 603.
9. 9. Nouri AME, Hussain RF, Dos Santos AVL, Gillott DJ, Oliver RTD. Induction of MHC antigens by tumour cell lines in response to interferons. Eur J Cancer 1992, 28, 110.
10. 10. Oliver R. New views on rejection mechanisms and their relevance to interleukin-2 as a treatment for renal cell cancer. Eur J Cancer 1991, 27, 1168-1172.
11. 11. Rosenberg S, Lotze M, Muul L, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987, 316, 889.
12. 12. Apperley J, Mauro F, Goldman J, et al. Bone marrow transplantation for chronic myeloid leukemia in first chronic phase: importance of a graft-versus-leukaemia effect. Br J Haematol 1988, 69, 239-245.
13. 13. Hughes T, Economou K, MacKinnon S, et al. Slow evolution of chronic myeloid leukaemia relapsing after BMT with T depleted donor marrow. B J Haematol 1989, 73, 462-467.
14. 14. Sosman J, Oettel K, Hank J, Fisch P, Sondel P. Specific recognition of human leukaemia cells by allogeneic T cell lines. Transplantation 1989, 48, 486-495.
15. + T cell clones with blast specific autologous cytotoxicity. Blood 1992, 80(Suppl.), 188a.
16. 16. Lim S, Worman C, Jewell A, Goldstone A. Cellular cytotoxic function and potential in acute myelogenous leukemia. Leukemia Res 1991, 15, 641-644.
17. 17. Brodsky FM, Parham P, Barn CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979, 47, 342-349.
18. 18. Lampson L, Levy R. Two populations of Ia molecules on a human B cell line. J Immunol 1980, 137, 2299-2302.
19. 19. Spier CM, Miller TP, Grogan TM. Deficient tumor-infiltrating T-lymphocyte response in malignant-lymphoma-relationship to HLA expression and host immunocompetence. Leukaemia 1993, 7, 398-403.
20. 20. Kawakami Y, Eliyahu S, Delgado DH, et al. Identification of a human-melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in-vivo tumor rejection. Proc Natl Acad Sci USA 1994, 91, 6458-6462.
21. 21. Boon T, Bruggen P van der. Human tumour antigens recognised by T lymphocytes. J Exp Med 1996, 183, 725-729.
22. 22. Belldegrum A, Linehan WM, Robertson N. Isolation and characterisation of lymphocytes infiltrating human renal cell cancer: possible application for therapeutic adoptive immunotherapy. Surg Forum 1986, 37, 671.
23. 23. Nouri AME, Bergbaum A, Lederer E, Crosby D, Shamsa A, Oliver RTD. Paired tumour infiltrating lymphocyte (TIL) and tumour cell line from bladder cancer: a new approach to study tumour immunology in vitro. Eur J Cancer 1991, 27, 608-612.
24. 24. Nouri AME, Dorey E, Davis CL, Rohatiner A, Lister TA, Oliver RTD. Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients. Cancer Immunol Immunother 1993, 37, 47-53.
25. 25. Dos Santos AVL, Nouri AME, Macey M, Sachs JA. Modulation of MHC and T cell antigens during allo-antigenic activation. Proc Eur Histocompatibility Conf 1990, 111.
26. 26. Lee SK, Oliver RTD. Autologous leukaemia specific T-cell mediated lymphotoxicity in patients with acute myeloid leukaemia. J Exp Med 1978, 147, 912-922.
27. 27. Oliver RTD, Lee S. Histocompatibility antigens and T cell responses to leukaemia antigens. In Reithmuller C, ed. Modern Trends in Leukaemia. Berlin, Springer, 1979, 377.
28. 28. Hirano N, Takahashi T, Takahashi T, et al. Expression of costimulatory molecules in human leukaemias. Leukemia 1996, 10, 1168-1176.
29. 29. Guerry D, Alexander MA, Herlyn MF, et al. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocyte. J Clin Invest 1984, 73, 267.
30. 30. Trowbridge IS, Omay MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci 1981, 78, 3039.